Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP Intra-ovarian Infusion in Menopausal Women
NCT03916978Phase 3Recruiting
- Sponsor
- Genesis Athens Clinic
- Start
- May 2019
- Primary completion
- Jan 2027
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of platelet-rich plasma injection in menopause and infertility (2 arms), sponsored by Genesis Athens Clinic. Primary endpoints: Restoration of menstrual cycle at 3 months and Serum Follicle Stimulating Hormone levels at 3 months. Started May 2019; status: recruiting.
02
Drugs
platelet-rich plasma injection
03
Conditions
menopauseinfertility
Beyond the preview
Go deeper on NCT03916978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03916978.